[Ocular side-effects in peroral treatment with anticholinergic agents].
D000065:Accommodation, Ocular / Q000187:drug effects; D000284:Administration, Oral; D000328:Adult; D001285:Atropine / Q000009:adverse effects; D001561:Benzilates / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005123:Eye / Q000187:drug effects*; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D010276:Parasympatholytics / Q000009:adverse effects*; D011680:Pupil / Q000187:drug effects; D011743:Pyrimidines / Q000009:adverse effects; D011759:Pyrrolidines / Q000009:adverse effects
D001561:Benzilates; D010276:Parasympatholytics; D011743:Pyrimidines; D011759:Pyrrolidines; C100201:oxyphencyclimine; D001285:Atropine
Ogonbiverkningar vid peroral behandling med antikolinergika.